Clinical Trials Directory

Trials / Unknown

UnknownNCT03338335

Ethnic Differences and the Ischemia/Bleeding Risk of DAPT Duration

Ethnic Differences in Ischemia/Bleeding Risk Tradeoff During Antiplatelet Therapy After Drug-eluting Stent Implantation

Status
Unknown
Phase
Study type
Observational
Enrollment
16,000 (estimated)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
19 Years – 100 Years
Healthy volunteers
Not accepted

Summary

this study is an individual patient level meta-analysis of randomized clinical trials, to evaluate the influence of ethnicity, to study whether the relative tradeoff between ischemia and bleeding is distinct by ethnicity.

Conditions

Interventions

TypeNameDescription
DRUGprolonged DAPTDual antiplatelet therapy will be prescribed for more than 12 months

Timeline

Start date
2017-03-01
Primary completion
2018-03-31
Completion
2018-10-31
First posted
2017-11-09
Last updated
2018-02-22

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03338335. Inclusion in this directory is not an endorsement.